UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 67 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,000 | +155.6% | 20,761 | +603.0% | 0.00% | – |
| Q3 2021 | $9,000 | -93.4% | 2,953 | -90.0% | 0.00% | – |
| Q2 2021 | $137,000 | -13.8% | 29,607 | +12.1% | 0.00% | – |
| Q1 2021 | $159,000 | +31.4% | 26,405 | +14.7% | 0.00% | – |
| Q4 2020 | $121,000 | +105.1% | 23,029 | +33.1% | 0.00% | – |
| Q3 2020 | $59,000 | -59.6% | 17,296 | +2.9% | 0.00% | – |
| Q2 2020 | $146,000 | +39.0% | 16,810 | -7.4% | 0.00% | – |
| Q1 2020 | $105,000 | -18.6% | 18,155 | +1.5% | 0.00% | – |
| Q4 2019 | $129,000 | +89.7% | 17,883 | +60.9% | 0.00% | – |
| Q3 2019 | $68,000 | -52.4% | 11,116 | -26.0% | 0.00% | – |
| Q2 2019 | $143,000 | +70.2% | 15,023 | +44.8% | 0.00% | – |
| Q1 2019 | $84,000 | -21.5% | 10,377 | +57.5% | 0.00% | – |
| Q4 2018 | $107,000 | +365.2% | 6,589 | +374.7% | 0.00% | – |
| Q3 2018 | $23,000 | +109.1% | 1,388 | +91.2% | 0.00% | – |
| Q2 2018 | $11,000 | – | 726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
| GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
| Caption Management, LLC | 725,000 | $409,000 | 0.01% |
| Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
| Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
| Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
| Caption Management, LLC | 225,000 | $127,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |